Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Guldsmed Nanna Schou ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   10.0% 11.6% 7.4% 3.7% 2.1% 3.2% 9.4% 9.2%   Credit score (0-100)   26 22 32 50 66 54 26 27   Credit rating   BB BB BB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   1,098 1,284 0 0 0 0 0 0   Gross profit   282 328 395 1,055 670 739 0.0 0.0   EBITDA   -28.0 -3.5 8.8 479 132 101 0.0 0.0   EBIT   -28.0 -3.5 8.8 471 124 92.2 0.0 0.0   Pre-tax profit (PTP)   -36.7 -7.5 8.5 459.5 112.5 85.9 0.0 0.0   Net earnings   -30.6 -25.1 6.7 359.8 86.9 66.8 0.0 0.0   Pre-tax profit without non-rec. items   -36.7 -7.5 8.5 460 112 85.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   159 134 71.8 432 518 585 459 459   Interest-bearing liabilities   0.0 0.0 309 252 256 263 0.0 0.0   Balance sheet total (assets)   572 582 650 1,301 1,146 1,150 459 459   Net Debt   -3.0 -56.2 161 -219 -118 -385 -425 -425     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   1,098 1,284 0 0 0 0 0 0   Net sales growth   2.7% 17.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   282 328 395 1,055 670 739 0.0 0.0   Gross profit growth   -28.2% 16.1% 20.6% 166.7% -36.5% 10.4% -100.0% 0.0%   Employees   0 0 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   572 582 650 1,301 1,146 1,150 459 459   Balance sheet change%   7.2% 1.8% 11.7% 100.0% -11.9% 0.3% -60.1% 0.0%   Added value   -28.0 -3.5 8.8 479.4 132.2 100.8 0.0 0.0   Added value %   -2.6% -0.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 60 -17 -17 -17 0 0   Net sales trend   2.0 3.0 -1.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   -2.6% -0.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   -2.6% -0.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -9.9% -1.1% 2.2% 44.6% 18.5% 12.5% 0.0% 0.0%   Net Earnings %   -2.8% -2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -2.8% -2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   -3.3% -0.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -5.1% -0.6% 1.5% 48.3% 10.1% 8.1% 0.0% 0.0%   ROI %   -16.1% -2.4% 3.6% 88.4% 17.0% 11.4% 0.0% 0.0%   ROE %   -17.5% -17.1% 6.5% 143.0% 18.3% 12.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   27.8% 23.0% 11.0% 33.2% 45.2% 53.8% 100.0% 100.0%   Relative indebtedness %   37.6% 34.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   37.4% 30.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   10.7% 1,623.0% 1,829.3% -45.6% -88.9% -381.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 430.5% 58.5% 49.4% 45.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.4% 4.0% 4.4% 2.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.4 0.4 0.8 0.9 1.3 0.0 0.0   Current Ratio   1.1 1.1 0.9 1.4 1.7 1.9 0.0 0.0   Cash and cash equivalent   3.0 56.2 148.3 471.2 373.8 648.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   22.4 27.1 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   137.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   42.3% 36.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   51.2 26.1 -36.2 332.1 427.6 502.9 0.0 0.0   Net working capital %   4.7% 2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 9 479 132 101 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 9 479 132 101 0 0   EBIT / employee   0 0 9 471 124 92 0 0   Net earnings / employee   0 0 7 360 87 67 0 0